Blockchain Registration Transaction Record

Streamline Scientific Launches Advanced UTI PCR Reporting to Combat Antibiotic Resistance

Streamline Scientific launches enhanced PCR reporting for UTI testing, integrating CLSI guidelines to reduce inappropriate antibiotic use and combat antimicrobial resistance through smarter diagnostics.

This development matters because antibiotic resistance represents one of the most critical public health threats of our time, with inappropriate prescribing contributing significantly to the problem. UTIs affect millions of Americans annually, and incorrect antibiotic treatment not only prolongs patient suffering but also accelerates the development of drug-resistant bacteria. By providing clinicians with clearer, guideline-based treatment recommendations directly from PCR test results, this service helps ensure patients receive the right antibiotics from the start, improving recovery outcomes while preserving the effectiveness of existing antibiotics for future patients. In an era where new antibiotic development has slowed dramatically, smarter use of existing medications through advanced diagnostic reporting becomes essential for maintaining effective healthcare delivery.